Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
posted on
Dec 05, 2019 08:47PM
RVXOT - Since it was a cardiovascular trial it seems kind of obvious that they were referring to cardiovascular disease patients that happened to have cognitive decline.
tada